ATCHISON, Kan., March 22, 2016 -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today announced that it will host an analyst day for institutional investors on Tuesday, April 5, 2016, at the company’s facility in Lawrenceburg, Ind. The event will include management presentations and a tour of the facility’s distillery and warehouse operations.
The presentations are expected to begin at approximately 10 a.m. EDT and last approximately an hour. A live audio webcast of the management presentations will be available on MGP’s Investor Relations site at www.mgpingredients.com. Presentation slides will be posted to the same site on the day of the event.
About MGP Ingredients, Inc.
Celebrating its 75th anniversary, MGP is a leading supplier of premium distilled spirits and specialty wheat proteins and starches. Distilled spirits include bourbon and rye whiskeys, gins and vodkas, which are carefully crafted through a combination of art and science and backed by a long history of experience. The company's proteins and starches are created in the same manner and provide a host of functional, nutritional and sensory benefits for a wide range of food products. MGP additionally is a top producer of high quality industrial alcohol for use in both food and non-food applications. The company is headquartered in Atchison, Kansas, where distilled alcohol products and food ingredients are produced. Premium spirits are also distilled and matured at the company’s facility in Lawrenceburg, Indiana. For more information, visit mgpingredients.com.
For More Information Investors & Analysts: Bob Burton 616-233-0500 or [email protected] Media: Steve Pickman Public Affairs Specialist 913.367.1480 [email protected]


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



